SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?


To: David Bogdanoff who wrote (962)7/16/1999 12:19:00 PM
From: bob zagorin  Read Replies (1) | Respond to of 1060
 
back on m. murphy. this excerpt from a report i got today touting his views shows what an idiot he can be in terms of timing

"...Michael Murphy, mutual fund manager and editor of California Technology Stock Letter made a bold move and shorted many of the Internet stocks around the beginning of the year. He has recently covered all of his short positions and thinks there will be many positive earnings surprises in the technology sector that will push the Internet stocks further up through a coat-tail effect..."



To: David Bogdanoff who wrote (962)8/17/1999 3:47:00 PM
From: David Bogdanoff  Read Replies (1) | Respond to of 1060
 
To all;

Interesting possible treatment for glaucoma involves inhibiting nitrous oxide to reduce intraocular pressure:
reutershealth.com .

Is the animal model for glaucoma valid? Comments anyone.

David